AC
DRTX

Aisling Capital’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Aisling Capital’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,030,175
Closed -$25.7M – 20
2014
Q3 		$25.7M Hold
2,030,175
– – 4.99% 10
2014
Q2 		$34.6M Sell
2,030,175
-1,000,000
-33% -$14.9M 9.99% 5
2014
Q1 		$40.8M Sell
3,030,175
-100,649
-3% -$1.32M 28.35% 2
2013
Q4 		$40M Buy
+3,130,824
New +$32.8M 24.45% 2

Aisling Capital's DRTX Position: Q4 2014 in Review

Aisling Capital sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 2,030,175 shares — an estimated $25.7M sold.

Aisling Capital first reported a position in DRTX in Q4 2013 and held it in 4 quarters. The position peaked at $40.8M in Q1 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Aisling Capital reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Aisling Capital sold 2,030,175 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $25.7M.
  • Aisling Capital first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 4 quarters.
  • Aisling Capital's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $40.8M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Aisling Capital's 13F filing for Q4 2014, filed 13 Feb 2015.